GenomeQuest/ NGS Leaders co-sponsored panel discussion which took place March 18, 2011 at X-GEN Congress in San Diego. The discussion was entitled Whole-Genome Sequencing Applied to Clinical Diagnostics: The Significance to the Research Community
Panelist questions: · What research and technological developments will help drive the advance to clinical?· What are real examples of benefits to patient care?· How can we better integrate research and clinical efforts/data to accelerate "translation"?· How will this start and expand? What's realistic for bottom-up and top-down progress? What timeframe? · Will this advance cause market disruption to the healthcare industry and how? · What does this mean for researchers and diagnostic companies? For regulators? · What are the potential bottlenecks and what can be done to address these concerns?
Five years from now, will sequencing centers have enough capacity to meet global demand?